Sara Spinler, BCPS, AQ-Cardiology, grew up in Minnesota and graduated from the University of Minnesota College of Pharmacy, where she learned from and trained with some of the early leaders of the “clinical pharmacy” movement. Following graduation, she completed two years of post-graduate residency and research fellowship at the University of Illinois at Chicago College of Pharmacy and Hospital, where she developed a practice and research interest in the field of cardiovascular medication use.
Prior to coming to Binghamton in 2018, Spinler taught students, was a program director for PGY1, PGY2 pharmacy residents and pharmaceutical industry fellows, and performed clinical research at Philadelphia College of Pharmacy (PCP), University of the Sciences in Philadelphia. Prior to leaving PCP, she was awarded the title professor emeritus. She is also an adjunct faculty member in the Cardiovascular Division in the Department of Medicine at the University of Pennsylvania.
Spinler has authored more than 300 research articles, reviews and book chapters and has given more than 400 continuing education programs in the areas of acute coronary syndrome, venous thromboembolism antiplatelets and anticoagulants.
- Spinler SA, Silvestry F. Valvular and pericardial diseases. In: Tisdale JE, Miller DA, editors. Drug-induced diseases: prevention, detection and management. Third edition. American Society of Health-Systems Pharmacists; 2018. p. 659-75.
- Rogers KC, Finks SW, Spinler SA. Acute coronary syndromes. In: Chisholm-Burns MA, Schwinghammer TL, Malone PM, Kolesar JM, Lee K, Bookstaver PB, eds. Pharmacotherapy principles and practice. Fifth Edition. New York: McGraw-Hill;2018. p. 117-144.
- Spinler SA. Acute coronary syndromes. In: Anticoagulation therapy. Dager WE, Gulseth MP, Nutescu EA, eds. Second Edition. Bethesda, Maryland: American Society of Health-System Pharmacists;2018. p. 363-391.
- Cheng JWM. Colucci VJ, Kalus JS, Spinler SA. Managing diabetes and preventing heart disease: have we found a safe and effective agent? Ann Pharmacother. 2019; 53:510-22. doi.org/10.1177/1060028018816466
- PharmD, University of Minnesota
- BS Pharmacy, University of Minnesota
- Quality of care and performance measures of cardiovascular medication use
- Anticoagulant use in patients with chronic kidney disease
- Anticoagulation reversal
- American Society of Health-System Pharmacists Award for Sustained Contributions to the Literature of Pharmacy Practice
- Fellow: American College of Clinical Pharmacy
- Fellow: American Heart Association: Clinical Cardiology Section
- Fellow: American Heart Association: Quality of Care and Outcomes Research Section
- Fellow: Philadelphia College of Physicians
- Fellow: American Society of Health-System Pharmacists
- Associate of the American College of Cardiology
- Philadelphia College of Pharmacy Excellence in Research and Scholarship Award
- Inducted into the Phi Lambda Sigma Pharmacy Leadership Society: Gamma Eta Chapter